Description
Composition (Each tablet contains):
-
Voglibose I.P.: 0.3 mg
-
Metformin Hydrochloride I.P. (Sustained Release): 500 mg
Dosage Form: Oral Sustained-Release Tablet
Therapeutic Class: Oral Antidiabetic (α-Glucosidase Inhibitor + Biguanide)
Voglibose & Metformin Hydrochloride Sustained-Release Tablets
VOGLIBOSE-0.3MG+METFORMIN HYDROCHLORIDE(SUSTAINED RELEASE)-500MG
